In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.

<h4>Background</h4>In vivo efficacy assessments of antimalarials are essential for ensuring effective case management. In Ethiopia, chloroquine (CQ) without primaquine is the first-line treatment for Plasmodium vivax in malarious areas, but artemether-lumefantrine (AL) is also commonly u...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jimee Hwang, Bereket Hailegiorgis Alemayehu, Richard Reithinger, Samuel Girma Tekleyohannes, Takele Teshi, Sintayehu Gebresillasie Birhanu, Leykun Demeke, David Hoos, Zenebe Melaku, Moges Kassa, Daddi Jima, Joseph L Malone, Henry Nettey, Michael Green, Amanda Poe, Sheila Akinyi, Venkatachalam Udhayakumar, S Patrick Kachur, Scott Filler
Format:	article
Langue:	EN
Publié:	Public Library of Science (PLoS) 2013
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/7f15c0baf4054c65ac7db520d8ae91dc
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.

Documents similaires